-
1
-
-
85026560488
-
Efficacy of liposomal amikacin for inhalation (LAI) in achieving nontuberculous mycobacteria (NTM) culture negativity in patients whose lung infection is refractory to guideline-based therapy
-
CENTRAL: 1136597; CFGD Register: PI281e; CRS: 5500050000000470; 4491036; EMBASE: 72054175]
-
Biller JA, Eagle G, McGinnis JP, Micioni L, Daley CL, Winthrop KL, et al. Efficacy of liposomal amikacin for inhalation (LAI) in achieving nontuberculous mycobacteria (NTM) culture negativity in patients whose lung infection is refractory to guideline-based therapy. American Journal of Respiratory and Critical Care Medicine 2015;191 Suppl. [CENTRAL: 1136597; CFGD Register: PI281e; CRS: 5500050000000470; 4491036; EMBASE: 72054175]
-
(2015)
American Journal of Respiratory and Critical Care Medicine
, vol.191
-
-
Biller, J.A.1
Eagle, G.2
McGinnis, J.P.3
Micioni, L.4
Daley, C.L.5
Winthrop, K.L.6
-
2
-
-
85006857423
-
Arikace® for Nontuberculous Mycobacteria
-
(accessed 01 October 2012). [ClinicalTrials.gov identifier: NCT01315236; 2852884]
-
NCT01315236 Arikace® for Nontuberculous Mycobacteria. www.clinicaltrials.gov/ct2/show/NCT01315236?term=arikace&rank=4 (accessed 01 October 2012). [ClinicalTrials.gov identifier: NCT01315236; 2852884]
-
-
-
-
3
-
-
85006862729
-
Randomized, double-blind, placebo-controlled, open-label study of liposomal amikacin for inhalation (LAI) in patients with recalcitrant nontuberculous mycobacterial lung disease (NTM-LD) [abstract]
-
CENTRAL: 1012528; CFGD Register: PI281a; CRS: 5500131000000183; 2852885]
-
Olivier KN, Eagle G, McGinnis II JP, Micioni L, Daley CL, Winthrop KL, et al. Randomized, double-blind, placebo-controlled, open-label study of liposomal amikacin for inhalation (LAI) in patients with recalcitrant nontuberculous mycobacterial lung disease (NTM-LD) [abstract]. Pediatric Pulmonology 2014;49 Suppl 38:321, Abstract no: 293. [CENTRAL: 1012528; CFGD Register: PI281a; CRS: 5500131000000183; 2852885]
-
(2014)
Pediatric Pulmonology
, vol.49
, pp. 321
-
-
Olivier, K.N.1
Eagle, G.2
McGinnis, J.P.3
Micioni, L.4
Daley, C.L.5
Winthrop, K.L.6
-
4
-
-
85006857529
-
Randomized, double-blind (DB), placebo-controlled study and open-label (OL) extension of liposomal amikacin for inhalation (LAI) in patients with refractory nontuberculous mycobacterial (NTM) lung disease (LD) [abstract]
-
CENTRAL: 1099086; CFGD Register: PI281b; CRS: 5500135000000023; 4491037]
-
Olivier KN, Eagle G, McGinnis JP, Micioni L, Daley CL, Winthrop KL, et al. Randomized, double-blind (DB), placebo-controlled study and open-label (OL) extension of liposomal amikacin for inhalation (LAI) in patients with refractory nontuberculous mycobacterial (NTM) lung disease (LD) [abstract]. Journal of Cystic Fibrosis: Official Journal of the European Cystic Fibrosis Society 2015;14 Suppl 1:S3, Abstract no: WS02.3. [CENTRAL: 1099086; CFGD Register: PI281b; CRS: 5500135000000023; 4491037]
-
(2015)
Journal of Cystic Fibrosis: Official Journal of the European Cystic Fibrosis Society
, vol.14
, pp. S3
-
-
Olivier, K.N.1
Eagle, G.2
McGinnis, J.P.3
Micioni, L.4
Daley, C.L.5
Winthrop, K.L.6
-
5
-
-
85026579565
-
Analysis of functional exercise capacity (via the six-minute walk test [6MWT]) and culture negativity in patients with nontuberculous mycobacteria (NTM) lung infection refractory to guideline-based therapy treated with liposomal amikacin for inhalation (LAI)
-
CENTRAL: 1136596; CFGD Register: PI281d; CRS: 5500050000000471; 4491038; EMBASE: 72054176]
-
Ruoss SJ, Eagle G, McGinnis JP, Micioni L, Daley CL, Winthrop KL, et al. Analysis of functional exercise capacity (via the six-minute walk test [6MWT]) and culture negativity in patients with nontuberculous mycobacteria (NTM) lung infection refractory to guideline-based therapy treated with liposomal amikacin for inhalation (LAI). American Journal of Respiratory and Critical Care Medicine 2015;191 Suppl. [CENTRAL: 1136596; CFGD Register: PI281d; CRS: 5500050000000471; 4491038; EMBASE: 72054176]
-
(2015)
American Journal of Respiratory and Critical Care Medicine
, vol.191
-
-
Ruoss, S.J.1
Eagle, G.2
McGinnis, J.P.3
Micioni, L.4
Daley, C.L.5
Winthrop, K.L.6
-
6
-
-
85006857411
-
Subgroup analyses of baseline demographics and efficacy in patients with refractory nontuberculous mycobacteria (NTM) lung infection treated with liposomal amikacin for inhalation (LAI)
-
CENTRAL: 1136598; CFGD Register: PI281c; CRS: 5500050000000472; 4491039; EMBASE: 72054174]
-
Winthrop KL, Eagle G, McGinnis JP, Micioni L, Daley CL, Ruoss SJ, et al. Subgroup analyses of baseline demographics and efficacy in patients with refractory nontuberculous mycobacteria (NTM) lung infection treated with liposomal amikacin for inhalation (LAI). American Journal of Respiratory and Critical Care Medicine 2015;191 Suppl. [CENTRAL: 1136598; CFGD Register: PI281c; CRS: 5500050000000472; 4491039; EMBASE: 72054174]
-
(2015)
American Journal of Respiratory and Critical Care Medicine
, vol.191
-
-
Winthrop, K.L.1
Eagle, G.2
McGinnis, J.P.3
Micioni, L.4
Daley, C.L.5
Ruoss, S.J.6
-
7
-
-
84855995836
-
Respiratory outbreak of Mycobacterium abscessus subspecies massiliense in a lung transplant and cystic fibrosis center
-
[PUBMED: 22246710]
-
Aitken ML, Limaye A, Pottinger P, Whimbey E, Goss CH, Tonelli MR, et al. Respiratory outbreak of Mycobacterium abscessus subspecies massiliense in a lung transplant and cystic fibrosis center. American Journal of Respiratory and Critical Care Medicine 2012;185(2):231-2. [PUBMED: 22246710]
-
(2012)
American Journal of Respiratory and Critical Care Medicine
, vol.185
, Issue.2
, pp. 231-232
-
-
Aitken, M.L.1
Limaye, A.2
Pottinger, P.3
Whimbey, E.4
Goss, C.H.5
Tonelli, M.R.6
-
8
-
-
0030963610
-
In vitro kinetics of drug release and pulmonary retention of microencapsulated antibiotic in liposomal formulations in relation to the lipid composition
-
Beaulac C, Clement-Major S, Hawari J, Lagace J. In vitro kinetics of drug release and pulmonary retention of microencapsulated antibiotic in liposomal formulations in relation to the lipid composition. Journal of Microencapsulation 1997;14(3):335-48.
-
(1997)
Journal of Microencapsulation
, vol.14
, Issue.3
, pp. 335-348
-
-
Beaulac, C.1
Clement-Major, S.2
Hawari, J.3
Lagace, J.4
-
9
-
-
84861888462
-
The use of a two-gene sequencing approach to accurately distinguish between the species within the Mycobacterium abscessus complex and Mycobacterium chelonae
-
Blauwendraat C, Dixon GL, Hartley JC, Foweraker J, Harris KA. The use of a two-gene sequencing approach to accurately distinguish between the species within the Mycobacterium abscessus complex and Mycobacterium chelonae. European Journal of Clinical Microbiology and Infectious Diseases 2012;31(8):1847-53.
-
(2012)
European Journal of Clinical Microbiology and Infectious Diseases
, vol.31
, Issue.8
, pp. 1847-1853
-
-
Blauwendraat, C.1
Dixon, G.L.2
Hartley, J.C.3
Foweraker, J.4
Harris, K.A.5
-
10
-
-
0035089052
-
First randomised trial of treatments for pulmonary disease caused by M avium intracellulare, M malmoense, and M xenopi in HIV negative patients: rifampicin, ethambutol and isoniazid versus rifampicin and ethambutol
-
British Thoracic Society. First randomised trial of treatments for pulmonary disease caused by M avium intracellulare, M malmoense, and M xenopi in HIV negative patients: rifampicin, ethambutol and isoniazid versus rifampicin and ethambutol. Thorax 2001;56(3):167-72.
-
(2001)
Thorax
, vol.56
, Issue.3
, pp. 167-172
-
-
-
11
-
-
0042816505
-
Pulmonary disease caused by Mycobacterium avium-intracellulare in HIV-negative patients: five-year follow-up of patients receiving standardised treatment
-
British Thoracic Society. Pulmonary disease caused by Mycobacterium avium-intracellulare in HIV-negative patients: five-year follow-up of patients receiving standardised treatment. International Journal of Tuberculosis and Lung Disease 2002;6(7):628-34.
-
(2002)
International Journal of Tuberculosis and Lung Disease
, vol.6
, Issue.7
, pp. 628-634
-
-
-
12
-
-
0021673622
-
Epidemiology of infection by nontuberculous mycobacteria. V. Numbers in eastern United States soils and correlation with soil characteristics
-
Brooks RW, Parker BC, Gruft H, Falkinham JO. Epidemiology of infection by nontuberculous mycobacteria. V. Numbers in eastern United States soils and correlation with soil characteristics. American Review of Respiratory Disease 1984;130(4):630-3.
-
(1984)
American Review of Respiratory Disease
, vol.130
, Issue.4
, pp. 630-633
-
-
Brooks, R.W.1
Parker, B.C.2
Gruft, H.3
Falkinham, J.O.4
-
13
-
-
84973867736
-
Nontuberculous mycobacteria in cystic fibrosis patients on the Island of Gran Canaria. A population study
-
Campos-Herrero MI, Chamizo FJ, Caminero JA, Gilarranz R, Cabrera G, Cuyas J. Nontuberculous mycobacteria in cystic fibrosis patients on the Island of Gran Canaria. A population study. Journal of Infection and Chemotherapy 2016;22(8):526-31.
-
(2016)
Journal of Infection and Chemotherapy
, vol.22
, Issue.8
, pp. 526-531
-
-
Campos-Herrero, M.I.1
Chamizo, F.J.2
Caminero, J.A.3
Gilarranz, R.4
Cabrera, G.5
Cuyas, J.6
-
14
-
-
84870762704
-
Mycobacterium avium and Mycobacterium abscessus complex target distinct cystic fibrosis patient subpopulations
-
Catherinot E, Roux AL, Vibet MA, Bellis G, Ravilly S, Lemonnier L, et al. Mycobacterium avium and Mycobacterium abscessus complex target distinct cystic fibrosis patient subpopulations. Journal of Cystic Fibrosis 2013;12(1):74-80.
-
(2013)
Journal of Cystic Fibrosis
, vol.12
, Issue.1
, pp. 74-80
-
-
Catherinot, E.1
Roux, A.L.2
Vibet, M.A.3
Bellis, G.4
Ravilly, S.5
Lemonnier, L.6
-
15
-
-
85006921483
-
Patient Data Registry Report 2014
-
(accessed 29 October 2012)
-
Cystic Fibrosis Canada. Patient Data Registry Report 2014. www.cysticfibrosis.ca/assets/files/pdf/cpdr_reporte.pdf (accessed 29 October 2012).
-
-
-
Cystic Fibrosis, C.1
-
16
-
-
85006897118
-
Patient Registry Report 2013
-
(accessed 29 October 2012)
-
Cystic Fibrosis Foundation. Patient Registry Report 2013. www.cff.org/LivingWithCF/QualityImprovement/PatientRegistryReport/# (accessed 29 October 2012).
-
-
-
-
17
-
-
84868285088
-
Macrolide treatment for Mycobacterium abscessus and M. massiliense infection and inducible resistance
-
2012 Aug 9 [Epub ahead of print]
-
Choi GE, Shin SJ, Won CJ, Min KN, Oh T, Hahn MY, et al. Macrolide treatment for Mycobacterium abscessus and M. massiliense infection and inducible resistance. American Journal of Respiratory and Critical Care Medicine 2012 Aug 9 [Epub ahead of print].
-
American Journal of Respiratory and Critical Care Medicine
-
-
Choi, G.E.1
Shin, S.J.2
Won, C.J.3
Min, K.N.4
Oh, T.5
Hahn, M.Y.6
-
19
-
-
0034773416
-
Statistical methods for the meta-analysis of cluster randomized trials
-
[PUBMED: 11697225]
-
Donner A, Piaggio G, Villar J. Statistical methods for the meta-analysis of cluster randomized trials. Statistical Methods in Medical Research 2001;10(5):325-38. [PUBMED: 11697225]
-
(2001)
Statistical Methods in Medical Research
, vol.10
, Issue.5
, pp. 325-338
-
-
Donner, A.1
Piaggio, G.2
Villar, J.3
-
20
-
-
0036211922
-
Meta-analyses involving cross-over trials: methodological issues
-
[PUBMED: 11914310]
-
Elbourne DR, Altman DG, Higgins JPT, Curtin F, Worthington HV, Vail A. Meta-analyses involving cross-over trials: methodological issues. International Journal of Epidemiology 2002;31(1):140-9. [PUBMED: 11914310]
-
(2002)
International Journal of Epidemiology
, vol.31
, Issue.1
, pp. 140-149
-
-
Elbourne, D.R.1
Altman, D.G.2
Higgins, J.P.T.3
Curtin, F.4
Worthington, H.V.5
Vail, A.6
-
21
-
-
21444440572
-
Nontuberculous mycobacterial infection in young children with cystic fibrosis
-
[PUBMED: 15858802]
-
Esther CR, Henry MM, Molina PL, Leigh MW. Nontuberculous mycobacterial infection in young children with cystic fibrosis. Pediatric Pulmonology 2005;40(1):39-44. [PUBMED: 15858802]
-
(2005)
Pediatric Pulmonology
, vol.40
, Issue.1
, pp. 39-44
-
-
Esther, C.R.1
Henry, M.M.2
Molina, P.L.3
Leigh, M.W.4
-
22
-
-
76749097178
-
Chronic Mycobacterium abscessus infection and lung function decline in cystic fibrosis
-
Esther CR Jr, Esserman DA, Gilligan P, Kerr A, Noone PG. Chronic Mycobacterium abscessus infection and lung function decline in cystic fibrosis. Journal of Cystic Fibrosis 2010;9(2):117-23.
-
(2010)
Journal of Cystic Fibrosis
, vol.9
, Issue.2
, pp. 117-123
-
-
Esther, C.R.1
Esserman, D.A.2
Gilligan, P.3
Kerr, A.4
Noone, P.G.5
-
23
-
-
0035286747
-
Factors influencing numbers of Mycobacterium avium, Mycobacterium intracellulare and other Mycobacteria in drinking water distribution systems
-
[PUBMED: 11229914]
-
Falkinham JO, Norton CD, Lechevallier MW. Factors influencing numbers of Mycobacterium avium, Mycobacterium intracellulare and other Mycobacteria in drinking water distribution systems. Applied and Environmental Microbiology 2001;67(3):1225-31. [PUBMED: 11229914]
-
(2001)
Applied and Environmental Microbiology
, vol.67
, Issue.3
, pp. 1225-1231
-
-
Falkinham, J.O.1
Norton, C.D.2
Lechevallier, M.W.3
-
24
-
-
0030895764
-
Mycobacterial lung disease in cystic fibrosis: a prospective study
-
[PUBMED: 9109135]
-
Fauroux B, Delaisi B, Clement A, Saizou C, Moissenet D, Truffot-Pernot C, et al. Mycobacterial lung disease in cystic fibrosis: a prospective study. Pediatric Infectious Disease Journal 1997;16(4):354-8. [PUBMED: 9109135]
-
(1997)
Pediatric Infectious Disease Journal
, vol.16
, Issue.4
, pp. 354-358
-
-
Fauroux, B.1
Delaisi, B.2
Clement, A.3
Saizou, C.4
Moissenet, D.5
Truffot-Pernot, C.6
-
25
-
-
84958211439
-
US Cystic Fibrosis Foundation and European Cystic Fibrosis Society consensus recommendations for the management of non-tuberculous mycobacteria in individuals with cystic fibrosis: executive summary
-
Floto RA, Olivier KN, Saiman L, Daley CL, Herrmann JL, Nick JA, et al. US Cystic Fibrosis Foundation and European Cystic Fibrosis Society consensus recommendations for the management of non-tuberculous mycobacteria in individuals with cystic fibrosis: executive summary. Thorax 2016;71(1):88-90.
-
(2016)
Thorax
, vol.71
, Issue.1
, pp. 88-90
-
-
Floto, R.A.1
Olivier, K.N.2
Saiman, L.3
Daley, C.L.4
Herrmann, J.L.5
Nick, J.A.6
-
26
-
-
0028129568
-
Effect of aerosolized recombinant human DNase on exacerbations of respiratory symptoms and on pulmonary function in patients with cystic fibrosis. The Pulmozyme Study Group
-
[PUBMED: 7503821]
-
Fuchs HJ, Borowitz DS, Christiansen DH, Morris EM, Nash ML, Ramsey BW, et al. Effect of aerosolized recombinant human DNase on exacerbations of respiratory symptoms and on pulmonary function in patients with cystic fibrosis. The Pulmozyme Study Group. New England Journal of Medicine 1994;331(10):637-42. [PUBMED: 7503821]
-
(1994)
New England Journal of Medicine
, vol.331
, Issue.10
, pp. 637-642
-
-
Fuchs, H.J.1
Borowitz, D.S.2
Christiansen, D.H.3
Morris, E.M.4
Nash, M.L.5
Ramsey, B.W.6
-
27
-
-
77954973769
-
Antibiotic susceptibility pattern of rapidly growing mycobacteria
-
[PUBMED: 20622384]
-
Gayathri R, Therese KL, Deepa P, Mangai S, Madhavan HN. Antibiotic susceptibility pattern of rapidly growing mycobacteria. Journal of Postgraduate Medicine 2010;56(2):76-8. [PUBMED: 20622384]
-
(2010)
Journal of Postgraduate Medicine
, vol.56
, Issue.2
, pp. 76-78
-
-
Gayathri, R.1
Therese, K.L.2
Deepa, P.3
Mangai, S.4
Madhavan, H.N.5
-
28
-
-
0033768032
-
Development of a disease specific health related quality of life measure for adults and adolescents with cystic fibrosis
-
[PUBMED: 11050265]
-
Gee L, Abbott J, Conway S, Etherington C, Webb A. Development of a disease specific health related quality of life measure for adults and adolescents with cystic fibrosis. Thorax 2000;55(11):946-54. [PUBMED: 11050265]
-
(2000)
Thorax
, vol.55
, Issue.11
, pp. 946-954
-
-
Gee, L.1
Abbott, J.2
Conway, S.3
Etherington, C.4
Webb, A.5
-
30
-
-
0027300451
-
Clinical features of pulmonary disease caused by rapidly growing mycobacteria. An analysis of 154 patients
-
[PUBMED: 8484642]
-
Griffith DE, Girard WM, Wallace RJ Jr. Clinical features of pulmonary disease caused by rapidly growing mycobacteria. An analysis of 154 patients. American Review of Respiratory Disease 1993;147(5):1271-8. [PUBMED: 8484642]
-
(1993)
American Review of Respiratory Disease
, vol.147
, Issue.5
, pp. 1271-1278
-
-
Griffith, D.E.1
Girard, W.M.2
Wallace, R.J.3
-
31
-
-
0029965596
-
Azithromycin activity against Mycobacterium avium complex lung disease in patients who were not infected with human immunodeficiency virus
-
Griffith DE, Brown BA, Girard WM, Murphy DT, Wallace RJ Jr. Azithromycin activity against Mycobacterium avium complex lung disease in patients who were not infected with human immunodeficiency virus. Clinical Infectious Diseases 1996;23(5):983-9.
-
(1996)
Clinical Infectious Diseases
, vol.23
, Issue.5
, pp. 983-989
-
-
Griffith, D.E.1
Brown, B.A.2
Girard, W.M.3
Murphy, D.T.4
Wallace, R.J.5
-
32
-
-
33847050904
-
An official ATS/IDSA statement: diagnosis, treatment, and prevention of nontuberculous mycobacterial diseases
-
[PUBMED: 17277290]
-
Griffith DE, Aksamit T, Brown-Elliott BA, Catanzaro A, Daley C, Gordin F, et al. An official ATS/IDSA statement: diagnosis, treatment, and prevention of nontuberculous mycobacterial diseases. American Journal of Respiratory and Critical Care Medicine 2007;175(4):367-416. [PUBMED: 17277290]
-
(2007)
American Journal of Respiratory and Critical Care Medicine
, vol.175
, Issue.4
, pp. 367-416
-
-
Griffith, D.E.1
Aksamit, T.2
Brown-Elliott, B.A.3
Catanzaro, A.4
Daley, C.5
Gordin, F.6
-
33
-
-
0041876133
-
Measuring inconsistency in meta-analyses
-
[PUBMED: 12958120]
-
Higgins JPT, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ 2003;327(7414):557-60. [PUBMED: 12958120]
-
(2003)
BMJ
, vol.327
, Issue.7414
, pp. 557-560
-
-
Higgins, J.P.T.1
Thompson, S.G.2
Deeks, J.J.3
Altman, D.G.4
-
37
-
-
47049114864
-
Clarithromycin vs ciprofloxacin as adjuncts to rifampicin and ethambutol in treating opportunist mycobacterial lung diseases and an assessment of Mycobacterium vaccae immunotherapy
-
Jenkins PA, Campbell IA, Banks J, Gelder CM, Prescott RJ, Smith AP. Clarithromycin vs ciprofloxacin as adjuncts to rifampicin and ethambutol in treating opportunist mycobacterial lung diseases and an assessment of Mycobacterium vaccae immunotherapy. Thorax 2008;63(7):627-34.
-
(2008)
Thorax
, vol.63
, Issue.7
, pp. 627-634
-
-
Jenkins, P.A.1
Campbell, I.A.2
Banks, J.3
Gelder, C.M.4
Prescott, R.J.5
Smith, A.P.6
-
38
-
-
84969941199
-
Investigation of Mycobacterium abscessus outbreak among cystic fibrosis patients, Hawaii 2012
-
Johnston DI, Chisty Z, Gross JE, Park SY. Investigation of Mycobacterium abscessus outbreak among cystic fibrosis patients, Hawaii 2012. Journal of Hospital Infection 2016;94(2):198-200.
-
(2016)
Journal of Hospital Infection
, vol.94
, Issue.2
, pp. 198-200
-
-
Johnston, D.I.1
Chisty, Z.2
Gross, J.E.3
Park, S.Y.4
-
39
-
-
41349117412
-
Multicenter cross-sectional study of nontuberculous mycobacterial infections among cystic fibrosis patients, Israel
-
[PUBMED: 18325250]
-
Levy I, Grisaru-Soen G, Lerner-Geva L, Kerem E, Blau H, Bentur L, et al. Multicenter cross-sectional study of nontuberculous mycobacterial infections among cystic fibrosis patients, Israel. Emerging Infectious Diseases 2008;14(3):378-84. [PUBMED: 18325250]
-
(2008)
Emerging Infectious Diseases
, vol.14
, Issue.3
, pp. 378-384
-
-
Levy, I.1
Grisaru-Soen, G.2
Lerner-Geva, L.3
Kerem, E.4
Blau, H.5
Bentur, L.6
-
41
-
-
0035451421
-
Failure of treatment for chronic Mycobacterium abscessus meningitis despite adequate clarithromycin levels in cerebrospinal fluid
-
Maniu CV, Hellinger WC, Chu SY, Palmer R, Alvarez-Elcoro S. Failure of treatment for chronic Mycobacterium abscessus meningitis despite adequate clarithromycin levels in cerebrospinal fluid. Clinical Infectious Diseases 2001;33(5):745-8.
-
(2001)
Clinical Infectious Diseases
, vol.33
, Issue.5
, pp. 745-748
-
-
Maniu, C.V.1
Hellinger, W.C.2
Chu, S.Y.3
Palmer, R.4
Alvarez-Elcoro, S.5
-
42
-
-
34547226095
-
In vitro efficacy of imipenem in combination with six antimicrobial agents against Mycobacterium abscessus
-
[PUBMED: 17616451]
-
Miyasaka T, Kunishima H, Komatsu M, Tamai K, Mitsutake K, Kanemitsu K, et al. In vitro efficacy of imipenem in combination with six antimicrobial agents against Mycobacterium abscessus. International Journal of Antimicrobial Agents 2007;30(3):255-8. [PUBMED: 17616451]
-
(2007)
International Journal of Antimicrobial Agents
, vol.30
, Issue.3
, pp. 255-258
-
-
Miyasaka, T.1
Kunishima, H.2
Komatsu, M.3
Tamai, K.4
Mitsutake, K.5
Kanemitsu, K.6
-
43
-
-
65649093032
-
A novel gene, erm (41), confers inducible macrolide resistance to clinical isolates of Mycobacterium abscessus but is absent from Mycobacterium chelonae
-
Nash KA, Brown-Elliott BA, Wallace RJ Jr. A novel gene, erm (41), confers inducible macrolide resistance to clinical isolates of Mycobacterium abscessus but is absent from Mycobacterium chelonae. Antimicrobial Agents and Chemotherapy 2009;53(4):1367-76.
-
(2009)
Antimicrobial Agents and Chemotherapy
, vol.53
, Issue.4
, pp. 1367-1376
-
-
Nash, K.A.1
Brown-Elliott, B.A.2
Wallace, R.J.3
-
44
-
-
85006922297
-
PREDICT Trial: PRospective Evaluation of NTM Disease In CysTic Fibrosis (PREDICT)
-
(first received 24 February 2014
-
NCT02073409 PREDICT Trial: PRospective Evaluation of NTM Disease In CysTic Fibrosis (PREDICT). clinicaltrials.gov/ct2/show/NCT02073409 (first received 24 February 2014.
-
-
-
-
45
-
-
85006943788
-
PATIENCE Trial: Prospective Algorithm for Treatment of NTM in Cystic Fibrosis (PATIENCE)
-
(first received: 09 December 2014)
-
NCT02419989 PATIENCE Trial: Prospective Algorithm for Treatment of NTM in Cystic Fibrosis (PATIENCE). clinicaltrials.gov/ct2/show/NCT02419989 (first received: 09 December 2014).
-
-
-
-
46
-
-
0037445273
-
Nontuberculous mycobacteria. II: nested-cohort study of impact on cystic fibrosis lung disease
-
[PUBMED: 12433669]
-
Olivier KN, Weber DJ, Lee JH, Handler A, Tudor G, Molina PL, et al. Nontuberculous mycobacteria. II: nested-cohort study of impact on cystic fibrosis lung disease. American Journal of Respiratory and Critical Care Medicine 2003;167(6):828-34. [PUBMED: 12433669]
-
(2003)
American Journal of Respiratory and Critical Care Medicine
, vol.167
, Issue.6
, pp. 828-834
-
-
Olivier, K.N.1
Weber, D.J.2
Lee, J.H.3
Handler, A.4
Tudor, G.5
Molina, P.L.6
-
47
-
-
40549117568
-
In vitro antimicrobial susceptibility of Mycobacterium abscessus in Korea
-
[PUBMED: 18303198]
-
Park S, Kim S, Park EM, Kim H, Kwon OJ, Chang CL, et al. In vitro antimicrobial susceptibility of Mycobacterium abscessus in Korea. Journal of Korean Medical Science 2008;23(1):49-52. [PUBMED: 18303198]
-
(2008)
Journal of Korean Medical Science
, vol.23
, Issue.1
, pp. 49-52
-
-
Park, S.1
Kim, S.2
Park, E.M.3
Kim, H.4
Kwon, O.J.5
Chang, C.L.6
-
48
-
-
0032583387
-
Extracting summary statistics to perform meta-analyses of the published literature for survival endpoints
-
[PUBMED: 9921604]
-
Parmar MK, Torri V, Stewart L. Extracting summary statistics to perform meta-analyses of the published literature for survival endpoints. Statistics in Medicine 1998;17(24):2815-34. [PUBMED: 9921604]
-
(1998)
Statistics in Medicine
, vol.17
, Issue.24
, pp. 2815-2834
-
-
Parmar, M.K.1
Torri, V.2
Stewart, L.3
-
49
-
-
22144468417
-
Age-related prevalence and distribution of nontuberculous mycobacterial species among patients with cystic fibrosis
-
[PUBMED: 16000480]
-
Pierre-Audigier C, Ferroni A, Sermet-Gaudelus I, Le Bourgeois M, Offredo C, Vu-Thien H, et al. Age-related prevalence and distribution of nontuberculous mycobacterial species among patients with cystic fibrosis. Journal of Clinical Microbiology 2005;43(7):3467-70. [PUBMED: 16000480]
-
(2005)
Journal of Clinical Microbiology
, vol.43
, Issue.7
, pp. 3467-3470
-
-
Pierre-Audigier, C.1
Ferroni, A.2
Sermet-Gaudelus, I.3
Le Bourgeois, M.4
Offredo, C.5
Vu-Thien, H.6
-
50
-
-
66649116259
-
Determination of the minimal clinically important difference scores for the Cystic Fibrosis Questionnaire-Revised respiratory symptom scale in two populations of patients with cystic fibrosis and chronic Pseudomonas aeruginosa airway infection
-
[PUBMED: 19447923]
-
Quittner AL, Modi AC, Wainwright C, Otto K, Kirihara J, Montgomery AB. Determination of the minimal clinically important difference scores for the Cystic Fibrosis Questionnaire-Revised respiratory symptom scale in two populations of patients with cystic fibrosis and chronic Pseudomonas aeruginosa airway infection. Chest 2009;135(6):1610-8. [PUBMED: 19447923]
-
(2009)
Chest
, vol.135
, Issue.6
, pp. 1610-1618
-
-
Quittner, A.L.1
Modi, A.C.2
Wainwright, C.3
Otto, K.4
Kirihara, J.5
Montgomery, A.B.6
-
51
-
-
84918560410
-
Epidemiology of nontuberculous mycobacteria among patients with cystic fibrosis in Scandinavia
-
Qvist T, Gilljam M, Jönsson B, Taylor-Robinson D, Jensen-Fangel S, Wang M, et al. Epidemiology of nontuberculous mycobacteria among patients with cystic fibrosis in Scandinavia. Journal of Cystic Fibrosis 2015;14(1):46-52.
-
(2015)
Journal of Cystic Fibrosis
, vol.14
, Issue.1
, pp. 46-52
-
-
Qvist, T.1
Gilljam, M.2
Jönsson, B.3
Taylor-Robinson, D.4
Jensen-Fangel, S.5
Wang, M.6
-
52
-
-
72449191789
-
Non-tuberculous mycobacteria in children with cystic fibrosis: isolation, prevalence, and predictors
-
Radhakrishnan DK, Yau Y, Corey M, Richardson S, Chedore P, Jamieson F, et al. Non-tuberculous mycobacteria in children with cystic fibrosis: isolation, prevalence, and predictors. Pediatric Pulmonology 2009;44(11):1100-6.
-
(2009)
Pediatric Pulmonology
, vol.44
, Issue.11
, pp. 1100-1106
-
-
Radhakrishnan, D.K.1
Yau, Y.2
Corey, M.3
Richardson, S.4
Chedore, P.5
Jamieson, F.6
-
53
-
-
71549145969
-
Multicenter study of prevalence of nontuberculous mycobacteria in patients with cystic fibrosis in France
-
[PUBMED: 19846643]
-
Roux AL, Catherinot E, Ripoll F, Soismier N, Macheras E, Ravilly S, et al. Multicenter study of prevalence of nontuberculous mycobacteria in patients with cystic fibrosis in France. Journal of Clinical Microbiology 2009;47(12):4124-8. [PUBMED: 19846643]
-
(2009)
Journal of Clinical Microbiology
, vol.47
, Issue.12
, pp. 4124-4128
-
-
Roux, A.L.1
Catherinot, E.2
Ripoll, F.3
Soismier, N.4
Macheras, E.5
Ravilly, S.6
-
54
-
-
84918818876
-
Comparing Mycobacterium massiliense and Mycobacterium abscessus lung infections in cystic fibrosis patients
-
Roux AL, Catherinot E, Soismier N, Heym B, Bellis G, Lemonnier L, et al. Comparing Mycobacterium massiliense and Mycobacterium abscessus lung infections in cystic fibrosis patients. Journal of Cystic Fibrosis 2015;14(1):63-9.
-
(2015)
Journal of Cystic Fibrosis
, vol.14
, Issue.1
, pp. 63-69
-
-
Roux, A.L.1
Catherinot, E.2
Soismier, N.3
Heym, B.4
Bellis, G.5
Lemonnier, L.6
-
55
-
-
0033954198
-
Demonstration of a fusion mechanism between a fluid bactericidal liposomal formulation and bacterial cells
-
Sachetelli S, Khalil H, Chen T, Beaulac C, Senechal S, Lagace J. Demonstration of a fusion mechanism between a fluid bactericidal liposomal formulation and bacterial cells. Biochimica et Biophysica Acta 2000;1463(2):254-66.
-
(2000)
Biochimica et Biophysica Acta
, vol.1463
, Issue.2
, pp. 254-266
-
-
Sachetelli, S.1
Khalil, H.2
Chen, T.3
Beaulac, C.4
Senechal, S.5
Lagace, J.6
-
56
-
-
79955553945
-
Mycobacterial infections in a large Virginia hospital, 2001-2009
-
Satyanarayana G, Heysell SK, Scully KW, Houpt ER. Mycobacterial infections in a large Virginia hospital, 2001-2009. BMC Infectious Diseases 2011;11:113.
-
(2011)
BMC Infectious Diseases
, vol.11
, pp. 113
-
-
Satyanarayana, G.1
Heysell, S.K.2
Scully, K.W.3
Houpt, E.R.4
-
57
-
-
10744228115
-
Mycobacterium abscessus and children with cystic fibrosis
-
[PUBMED: 14720400]
-
Sermet-Gaudelus I, Le Bourgeois M, Pierre-Audigier C, Offredo C, Guillemot D, Halley S, et al. Mycobacterium abscessus and children with cystic fibrosis. Emerging Infectious Diseases 2003;9(12):1587-91. [PUBMED: 14720400]
-
(2003)
Emerging Infectious Diseases
, vol.9
, Issue.12
, pp. 1587-1591
-
-
Sermet-Gaudelus, I.1
Le Bourgeois, M.2
Pierre-Audigier, C.3
Offredo, C.4
Guillemot, D.5
Halley, S.6
-
59
-
-
85006070879
-
Emended description of Mycobacterium abscessus, Mycobacterium abscessus subs. abscessus, Mycobacterium abscessus subsp. bolletii and designation of Mycobacterium abscessus subsp. massiliense comb. nov
-
Tortoli E, Kohl TA, Brown-Elliott BA, Trovato A, Cardoso Leao S, Garcia MJ, et al. Emended description of Mycobacterium abscessus, Mycobacterium abscessus subs. abscessus, Mycobacterium abscessus subsp. bolletii and designation of Mycobacterium abscessus subsp. massiliense comb. nov. International Journal of Systematic and Evolutionary Microbiology 2016;66(11):4471-9.
-
(2016)
International Journal of Systematic and Evolutionary Microbiology
, vol.66
, Issue.11
, pp. 4471-4479
-
-
Tortoli, E.1
Kohl, T.A.2
Brown-Elliott, B.A.3
Trovato, A.4
Cardoso Leao, S.5
Garcia, M.J.6
-
60
-
-
0028316355
-
Initial clarithromycin monotherapy for Mycobacterium avium-intracellulare complex lung disease
-
Wallace RJ Jr, Brown BA, Griffith DE, Girard WM, Murphy DT, Onyi GO, et al. Initial clarithromycin monotherapy for Mycobacterium avium-intracellulare complex lung disease. American Journal of Respiratory and Critical Care Medicine 1994;149(5):1335-41.
-
(1994)
American Journal of Respiratory and Critical Care Medicine
, vol.149
, Issue.5
, pp. 1335-1341
-
-
Wallace, R.J.1
Brown, B.A.2
Griffith, D.E.3
Girard, W.M.4
Murphy, D.T.5
Onyi, G.O.6
-
61
-
-
0029888154
-
Clarithromycin regimens for pulmonary Mycobacterium avium complex. The first 50 patients
-
Wallace RJ Jr, Brown BA, Griffith DE, Girard WM, Murphy DT. Clarithromycin regimens for pulmonary Mycobacterium avium complex. The first 50 patients. American Journal of Respiratory and Critical Care Medicine 1996;153(6 Pt 1):1766-72.
-
(1996)
American Journal of Respiratory and Critical Care Medicine
, vol.153
, Issue.6 PART. 1
, pp. 1766-1772
-
-
Wallace, R.J.1
Brown, B.A.2
Griffith, D.E.3
Girard, W.M.4
Murphy, D.T.5
-
62
-
-
0036783671
-
Comparison of the in vitro activity of the glycylcycline tigecycline (formerly GAR-936) with those of tetracycline, minocycline, and doxycycline against isolates of nontuberculous mycobacteria
-
[PUBMED: 12234839]
-
Wallace RJ Jr, Brown-Elliott BA, Crist CJ, Mann L, Wilson RW. Comparison of the in vitro activity of the glycylcycline tigecycline (formerly GAR-936) with those of tetracycline, minocycline, and doxycycline against isolates of nontuberculous mycobacteria. Antimicrobial Agents and Chemotherapy 2002;46(10):3164-7. [PUBMED: 12234839]
-
(2002)
Antimicrobial Agents and Chemotherapy
, vol.46
, Issue.10
, pp. 3164-3167
-
-
Wallace, R.J.1
Brown-Elliott, B.A.2
Crist, C.J.3
Mann, L.4
Wilson, R.W.5
-
63
-
-
84856421613
-
New treatments for emerging cystic fibrosis pathogens other than Pseudomonas
-
Waters V. New treatments for emerging cystic fibrosis pathogens other than Pseudomonas. Current Pharmaceutical Design 2012;18(5):696-725.
-
(2012)
Current Pharmaceutical Design
, vol.18
, Issue.5
, pp. 696-725
-
-
Waters, V.1
-
64
-
-
0027531962
-
Improved recovery of mycobacteria from respiratory secretions of patients with cystic fibrosis
-
Whittier S, Hopfer RL, Knowles MR, Gilligan PH. Improved recovery of mycobacteria from respiratory secretions of patients with cystic fibrosis. Journal of Clinical Microbiology 1993;31(4):861-4.
-
(1993)
Journal of Clinical Microbiology
, vol.31
, Issue.4
, pp. 861-864
-
-
Whittier, S.1
Hopfer, R.L.2
Knowles, M.R.3
Gilligan, P.H.4
-
65
-
-
0037764104
-
High prevalence of antimicrobial resistance in rapidly growing mycobacteria in Taiwan
-
[PUBMED: 12760874]
-
Yang SC, Hsueh PR, Lai HC, Teng LJ, Huang LM, Chen JM, et al. High prevalence of antimicrobial resistance in rapidly growing mycobacteria in Taiwan. Antimicrobial Agents and Chemotherapy 2003;47(6):1958-62. [PUBMED: 12760874]
-
(2003)
Antimicrobial Agents and Chemotherapy
, vol.47
, Issue.6
, pp. 1958-1962
-
-
Yang, S.C.1
Hsueh, P.R.2
Lai, H.C.3
Teng, L.J.4
Huang, L.M.5
Chen, J.M.6
-
66
-
-
84874166229
-
Antibiotic treatment for nontuberculous mycobacteria lung infection in people with cystic fibrosis
-
Waters V, Ratjen F. Antibiotic treatment for nontuberculous mycobacteria lung infection in people with cystic fibrosis. Cochrane Database of Systematic Reviews 2012, Issue 7. [DOI: 10.1002/14651858.CD010004]
-
(2012)
Cochrane Database of Systematic Reviews
, Issue.7
-
-
Waters, V.1
Ratjen, F.2
-
67
-
-
84874166229
-
Antibiotic treatment for nontuberculous mycobacteria lung infection in people with cystic fibrosis
-
Waters V, Ratjen F. Antibiotic treatment for nontuberculous mycobacteria lung infection in people with cystic fibrosis. Cochrane Database of Systematic Reviews 2012, Issue 12. [DOI: 10.1002/14651858.CD010004.pub2]
-
(2012)
Cochrane Database of Systematic Reviews
, Issue.12
-
-
Waters, V.1
Ratjen, F.2
-
68
-
-
84925223178
-
Antibiotic treatment for nontuberculous mycobacteria lung infection in people with cystic fibrosis
-
Waters V, Ratjen F. Antibiotic treatment for nontuberculous mycobacteria lung infection in people with cystic fibrosis. Cochrane Database of Systematic Reviews 2014, Issue 12. [DOI: 10.1002/14651858.CD010004.pub3]
-
(2014)
Cochrane Database of Systematic Reviews
, Issue.12
-
-
Waters, V.1
Ratjen, F.2
|